Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

at the highest dose The pill could make treatment easier for people who don’t want to inject themselves FRIDAY, April 18, ...

Eli Lilly said its drugs showed no signs of live injury in the trial. This is welcome news for researchers after Pfizer ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...